Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2022-07-07 00:00:00 ET · period of report 2022-07-05 · accession 0001735276-22-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-07 | 2022-07-05 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $150.00 | -1,754 | 1,754 | -50% | -$263.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-05 | S | D | 1,754 | $150.00 | 1,754 | D | — | — |